Study of anifrolumab for lupus patients needing treatment
Treatments studied
Part of Immune system & allergy, Skin clinical trials.
This study looks at how well anifrolumab works for people with systemic lupus erythematosus (SLE) who are starting it for the first time. It aims to see if patients can achieve a low disease activity state (LLDAS5) after treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have been diagnosed with systemic lupus erythematosus (SLE) using the 2019 EULAR/ACR criteria.
- You are prescribed anifrolumab for SLE for the first time, following Italian guidelines.
- You cannot have already achieved a low disease activity state (LLDAS5) at the start of the study.
- You must not have taken anifrolumab before.
- You must not have severe lupus kidney disease (like active class III or IV nephritis) or unstable brain/lupus symptoms.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with lupus who are starting a new medication called anifrolumab (given as a shot under the skin) as part of their regular medical care. It aims to see how well the medicine works in everyday life.
This trial tests anifrolumab, an investigational drug that may help reduce lupus activity in people with moderate-to-severe disease. If you have active lupus despite current treatments, this study might offer a new option.
This study looks at how well anifrolumab works for people with lupus in everyday medical care, not just in a research lab. It may help you if your doctor has decided to prescribe anifrolumab for the first time.
This trial tests if a new drug called anifrolumab can help treat lupus in people who haven't taken strong medications like biologics or immunosuppressants before. It looks at overall disease activity and the chance to reduce steroid use.
This trial tests anifrolumab, given as a shot under the skin or through a vein, to see how it works in people with lupus. It may help if you have active lupus symptoms and are on standard treatments.
This study tracks how well anifrolumab works and how safe it is for people with active lupus. It's a real-world look at the drug's effects, so no additional treatments or tests are required beyond what your doctor already prescribes.
Hear when a new Lupus Erythematosus, Systemic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.